"We were expecting prices of anti-diabetic medicine Empagliflozin to crash as the medicine went off patent earlier this month. The industry was expecting a price drop by as much as 90%. The same ...

Researchers, including those at the University of North Carolina, US, found that the oral form of Semaglutide can ...

Broad access to new obesity drugs leads to longer, healthier lives, delivering a substantial societal return on investment, ...

A team of scientists has found new clues that could change how we think about aging. Their work suggests that aging might not ...

Beginning April 1, prices for essential drugs like painkillers, antibiotics, and anti-diabetic medicines will rise by 1.74%.

Anti-obesity drugs, specifically GLP-1 agonists, have been shown to benefit kidney transplant recipients with type 2 diabetes by reducing the risk of organ failure by 49% and decreasing mortality ...

Essential medicines for managing conditions like diabetes, cancer, heart disease, and bacterial infections such as painkillers, antibiotics, anti-infectives, anti-diabetics and cancer drugs are set to ...

rose from its second meeting in three days yesterday with the approval of N10.299 billion for the procurement of diagnostic kits for diabetes, anti retroviral drugs for resistant HIV/Aids patients ...

Eli Lilly launches diabetes and obesity drug Mounjaro in India, offering innovative treatment for metabolic health management ...

Past studies have shown that the human sweet taste receptor conveys sweet perception in the mouth and may help regulate glucose metabolism throughout the body.

New findings reveal a chilling link between type 2 diabetes and a hidden danger. The truth could change how we see both ...

Eli Lilly launches anti-obesity and diabetes drug Mounjaro in India, priced competitively at Rs 14,000-17,500, a fraction of ...